Ignite Creation Date:
2025-12-25 @ 2:44 AM
Ignite Modification Date:
2026-02-22 @ 6:45 PM
Study NCT ID:
NCT02298933
Status:
COMPLETED
Last Update Posted:
2019-01-03
First Post:
2014-11-21
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Complement Inhibition Using Eculizumab to Overcome Platelet Transfusion Refractoriness in Patients With Severe Thrombocytopenia
Sponsor:
National Heart, Lung, and Blood Institute (NHLBI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-11-21
Start Date Type:
None
Primary Completion Date:
2017-08-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-08-08
Completion Date Type:
ACTUAL
First Submit Date:
2014-11-21
First Submit QC Date:
None
Study First Post Date:
2014-11-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-12-12
Results First Submit QC Date:
None
Results First Post Date:
2019-01-03
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-12-12
Last Update Post Date:
2019-01-03
Last Update Post Date Type:
ACTUAL